RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 28 - per page Previous page Next page
Order by
Manufacture Microbubble with very homogeneous diameters and distinct shell thickness/strength (07-46)
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
Cripto-1 as a Biomarker for Cardiac Ischemia
Cripto-1 is overexpressed in infarcted myocardial tissue More
Bipodal-Peptide Binder
Peptide molecules to specifically bind targets such as aptamer, avimer and kunitz domain have been intensively studied and developed as alternatives to antibodies. More
Device and Methods for In Vivo Flow Cytometry: Non-invasive and Sensitive Detection of Circulating Cancer Cells using Photoacoustic Waves (08-16)
non invasive in vivo detection of cells circulating in blood or lymphatic vessels More
Cardiovascular Risk Assessment (02-01)
Diagnosis of functional heart disease and heart disease prognostication with emphasis on the multifractal alpha, the Levy flight analysis and the key discrete wavelet smoothing. More
Methods for screening a therapeutic agent of heart failure, fibrosis and inflammation and compositions comprising the same
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Tears as a Non Invasive Screening Medium (05-11)
Screening tool for the detection of breast and other cancers More
Prolactin Receptor Antibodies as a Diagnostic Marker and Therapeutic Agent for Cancer
This technology describes several antibodies, both polyclonal and monoclonal, to the prolactin receptor. More
Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy (09-08)
An expression array diagnostic tool to predict survival in cancer patients, as well as, composition and methods to induce the predictive gene expression profile More
Extracellular Matrix Gene Chips to Detect Metastatic Tumors
These gene chips detect the over-expression of the cancer-related extracellular matrix (ECM) modifier proteins Anakin and Bromodomain 4 (Brd4). More
Displaying 11..20 of 28 - per page Previous page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
SomaLogic, Inc. - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
MND Diagnostic LTD - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
Protagen AG - Product Pipeline Analysis
Nov 2010 - 27 pages - $750
Innova Biotechnology Co., Ltd. - Product Pipeline Analysis
Mar 2011 - 13 pages - $750
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
DioGenix, Inc. - Product Pipeline Analysis
Mar 2011 - 18 pages - $750
Miraculins Inc. (MOM) - Product Pipeline Analysis
Mar 2011 - 20 pages - $750
Miraculins Inc. (MOM) - Product Pipeline Analysis
Nov 2010 - 26 pages - $750
Chronix Biomedical, Inc. - Product Pipeline Analysis
Mar 2011 - 18 pages - $750
Mitomics Inc. - Product Pipeline Analysis
Mar 2011 - 22 pages - $750
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us